Bio Protocol has completed a $6.9 million seed round financing, led by Arthur Hayes's Maelstrom Fund

BlockBeats News, September 17th, Bio Protocol completed a $6.9 million seed round of financing, led by Arthur Hayes's Maelstrom Fund. Other participants include Mechanism Capital, Animoca Brands, Zee Prime Capital, Panga Capital, Mirana Ventures, Foresight Ventures, Big Brain Holdings, among others.

Bio Protocol will launch an AI-based decentralized science platform for biotech financing and drug discovery. This financing coincides with the launch of Bio V2, which introduces on-chain funding and a decentralized AI-driven framework for early-stage scientific research and development. Researchers, patients, and the crypto community can use BioAgents to generate scientific hypotheses, monetize discoveries, and uncover hidden insights in the field of biology faster than traditional biotech. Bio plans to globally expand the BioAgent framework to other researchers and labs, creating a decentralized scientific machine network to build and monetize biotech research beyond traditional pharmaceutical structures.

Arthur Hayes stated that Bio is poised to become a category-defining launch platform that will fund scientifically attractive research for the community, not just academia. If successful, this will not only be a launch platform—it will also mark the birth of an AI-native research marketplace.